23.79k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | +0.37% | - | - | - |
^GSPC | +0.41% | +4.28% | +15.38% | +4850.94% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 154.42 | -0.98 | -0.63% | 4:00 pm GMT-5 | 4.73M | 6.76M | 371.73B |
ABBV | AbbVie Inc. | 149.28 | +1.31 | +0.89% | 4:00 pm GMT-5 | 5.58M | 4.95M | 263.56B |
PFE | Pfizer Inc. | 28.78 | +0.15 | +0.52% | 4:00 pm GMT-5 | 27.71M | 31.41M | 162.50B |
SNY | Sanofi | 46.32 | +0.26 | +0.56% | 4:00 pm GMT-5 | 1.33M | 2.07M | 116.16B |
GILD | Gilead Sciences, Inc. | 79.02 | +0.97 | +1.24% | 4:00 pm GMT-5 | 6.20M | 5.81M | 98.46B |
REGN | Regeneron Pharmaceuticals, Inc. | 840.14 | -9.04 | -1.06% | 4:00 pm GMT-5 | 359.16k | 454.25k | 91.53B |
GSK | GSK plc | 35.94 | -0.06 | -0.17% | 4:00 pm GMT-5 | 1.51M | 3.53M | 74.02B |
TAK | Takeda Pharmaceutical Company Limited | 14.06 | -0.02 | -0.14% | 4:00 pm GMT-5 | 838.17k | 1.85M | 44.12B |
MRNA | Moderna, Inc. | 80.32 | +0.37 | +0.46% | 4:00 pm GMT-5 | 2.75M | 4.11M | 30.62B |
BNTX | BioNTech SE | 103.43 | +1.50 | +1.48% | 4:00 pm GMT-5 | 452.62k | 656.24k | 24.80B |
VIR | Vir Biotechnology, Inc. | 9.62 | +0.03 | +0.31% | 4:00 pm GMT-5 | 893.26k | 1.42M | 1.29B |
NVAX | Novavax, Inc. | 5.57 | +0.04 | +0.72% | 4:00 pm GMT-5 | 4.99M | 7.75M | 661.66M |
INO | Inovio Pharmaceuticals, Inc. | 0.38 | +0.00 | +0.53% | 4:00 pm GMT-5 | 1.64M | 3.42M | 103.73M |
I have always stated that stocks should not be bought just because they trade at a 52-week low. A new 52-week low does not make a particular stock cheap. In today's video I will look at three dividend stocks trading at their 52-week lows and examine their metrics to determine if the stock is cheap or not.
Readers hoping to buy Gilead Sciences, Inc. ( NASDAQ:GILD ) for its dividend will need to make their move shortly, as...
Shares of Pfizer (NYSE: PFE) have been in an endless tailspin this year -- now down more than 40%. Revenue from its COVID-19 products is down big, and investors are concerned about looming patent cliffs for the business in the years ahead. Let's look at what happened -- and Pfizer's prospects for overcoming this latest challenge.